Background: Different questionnaires have been used to evaluate patients with Obstructive sleep apnea/hypopnea syndrome (OSAHS). The 4-Variable screening tool (4-V) was developed and validated in Asian population for identifying moderate to severe OSAHS. Aims and Objectives: To evaluate the ability of 4-V to identify patients at high risk for OSAHS in a European Population visiting a Sleep Clinic. Methods: 1057 (73.8% males), 52±14 years, BMI 33±7kg/m 2 , Epworth Sleepiness Scale (ESS) 11.5±5.4 and Apnea Hypopnea Index (AHI) 32.7±26.5 were included. All patients had an in laboratory sleep study and 4-V was calculated. Results: The mean 4-V score was 13.3±2.5. Sensitivities of 4-V≥11 for AHI ≥5, ≥15 and ≥30 were 78%, 79% and 81%, respectively; specifi cities 40.8%, 36%, 32%; positive predictive values (PPV) 84.3%, 71%, 52%; negative predictive values (NPV) 31%, 46.5%, 65% and area under the ROC curve at AHI≥ 15 was 0.58. For 4-V ≥14, sensitivities for AHI ≥5, ≥15 and ≥30 were 50.7%, 55% and 61%, respectively; specifi cities 78%, 74.4%, 69%; PPV 90.3%, 81%, 64%; NPV 27.9%, 45%, 66% and area under the ROC curve at AHI≥ 15 was 0.68. The 4-V differed signifi cantly between no and mild and between moderate and severe OSAHS, but not between mild and moderate OSAHS in both genders. Sensitivity was better in men, but specifi city was higher in women. Conclusion: In Caucasians the 4-V≥14 had low sensitivity and NPV, rather good specifi city and PPV. For a cut-off≥11, sensitivity was better but specifi city was low. However the predictive values differed between genders.
INTRODUCTION
Obstructive sleep apnea hypopnea syndrome (OSAHS) prevalence among middle-aged population ranges from 2-9% 1 and has been recognized as an important cause of morbidity and mortality as it is associated with a wide range of medical consequences (hypertension, cardiovascular diseases, psychological effects) and accidents. 2, 3 Polysomnography (PSG) has been used as the gold standard for OSAHS diagnosis but is time consuming and expensive. Different clinical models and questionnaires have been used to evaluate patients with the highest OSAHS probability in order to save time and money. The ideal screening test should be inexpensive, simple, non time consuming, with high sensitivity in order to detect patients with OSAHS early in the disease process and with sufficient specificity to eliminate unnecessary testing. [4] [5] [6] [7] [8] Such a screening tool would greatly assist clinicians and researchers in the investigation and treatment of OSAHS.
Evaluating four -variable screening tool in european population of a sleep clinic for assessing obstructive sleep apnea syndrome
The 4-Variable screening tool (4-V) was developed and validated in Japan from Takegami et al 5 as a tool for the identifi cation of moderate to severe sleep-disordered breathing (SDB) with the knowledge of only 4 easily ascertainable variables (gender, blood pressure (BP) level, body mass index (BMI) and self-reported snoring). It has been found that the phenotype of OSAHS is infl uenced by race, with Asians with OSAHS having greater restriction in skeletal measurements and Caucasians being more obese. The aim of our study was to evaluate the ability of the 4-V to identify the patients with higher risk of OSAHS as measured by Apnea Hypopnea Index (AHI) in Caucasian Population visiting a Sleep Clinic.
MATERIALS AND METHODS
The data of the patients visiting the Sleep Clinic of the Respiratory Failure Unit of G Papanikolaou Hospital from 2009 to 2012 were retrospectively studied. The ethics committee reviewed and approved the protocol and did not require patient consent. Patients>18 years, referred for the evaluation of a possible sleep disorder who underwent inlaboratory polysomnography were included. Patients with previous diagnosis of OSAHS or another sleep disorder as narcolepsy, Continuous Positive Airway Pressure (CPAP) use or missing data were excluded. Sleepiness was evaluated with the Epworth Sleepiness Scale (ESS). ESS is a self-administered questionnaire for measuring subjective daytime sleepiness (8 questions). Scores above 10 are considered as abnormal sleepiness.
6,7 BMI, age, neck circumference, gender and sitting BP were documented from a sleep technician.
The 4-V 5 consists of four variables (gender, BP, BMI and self-reported snoring). The following equation was used for the calculation of the 4-V: OSAHS = (gender*4) + (BMI category value) + (BP category value) + (snoring*4). Gender: females were scored with 0 and males with 1. BMI category value: BMI (kg/m 2 ) was categorised as < 21.0, 21.0-22.9, 23.0-24.9, 25.0-26.9, 27.0-29.9, ≥ 30 and values from 1 to 6 were assigned respectively according to Takegami et al. 5 BP category value: Blood pressure (BP) (mmHg) was categorised as systolic BP (SBP) < 140 or diastolic BP (DBP) < 90, SBP 140-159 or DBP 90-99, SBP160-179 or DBP 100-109, SBP ≥ 180 or DBP ≥ 110 and values between 1 and 4 were assigned respectively. 5 Snoring sometimes or almost never was considered as "no" and was scored with 0 and snoring almost everyday or often was considered as 'yes' and was scored with 1. We evaluated the cut-offs of ≥11 and ≥14 according to Takegami et al. 5 All the participants underwent PSG in-laboratory consisting of electroencephalog raphy (EEG), electrooculography (EOG), submental electromyography (EMG), electrocardiography (ECG), snoring (microphone on anterior neck), airfl ow (by oronasal thermistor and nasal air pressure transducer), body position detection, thoracic and abdominal respiratory effort and oximetry (Alice 5 Diagnostic Sleep System, Philips Respironics). The American Academy of Sleep Medicine (AASM) guidelines were used for PSG manual scoring. 9 Apnea Hypopnea Index (AHI) was defi ned as the number of apneas and hypopneas per hour of sleep. Oxygen Desaturation Index (ODI) was defi ned as the number of desaturations >4% divided by the time in bed. 10 Apneas were defi ned as the drop of airfl ow ≥90% of baseline for at least 10 sec and hypopneas as a decrease in airfl ow of at least 30% for at least 10 sec with oxygen desaturation of ≥4% from preevent baseline. 11 The severity of OSAHS was determined by the AHI: 5-14.9 as mild; 15-29.9 as moderate; ≥ 30 as severe.
11 AHI≥5 involves all patients with OSAHS, AHI≥15 involves patients with moderate and severe OSAHS and AHI≥30 patients with severe OSAHS.
Statistical analysis
SPSS version 17.0 (SPSS Science, Apache Software Foundation, Chicago, IL, USA) was used. The normality of data distribution was tested with Shapiro Wilks. Sensitivity, specificity, positive predictive values (PPV), negative predictive values (NPV), positive and negative likelihood ratios (LR+/LR-) were calculated. Bivariate logistic regression models were used to determine the odds ratio (OR) in predicting OSAHS. The Pearson correlation (for normally distributed) and Spearman correlation (for non normally distributed data) were used to evaluate if there were signifi cant correlations between different variables. The chi-square test was used for categorical variables. Data were presented as mean±SD unless otherwise stated. Analysis of variance (ANOVA) with post hoc contrasts by t tests for normally distributed continuous variables (Bonferroni) was used for the analysis of the differences between group means. For non normally distributed data the Kruskal-Wallis test was used. Tests were two-tailed and p<0.05 was accepted as statistically signifi cant. The discriminatory ability of the 4-V for diagnosing OSAHS was evaluated using receiver operating characteristic (ROC) curves.
RESULTS
From the 1850 patients that visited the Sleep Clinic, 1057 (73.8% males) with a mean age 52 ±14 years, BMI 33±7 kg/m 2 and AHI 32.7±26.5 were included in the study. Seven hundred ninety three patients (42.8%) were excluded. Patients who were previously diagnosed with OSAHS (n=210) or already used CPAP (n=235) or had another sleep disorder (n=32) were excluded. Patients with missing data (n=316) were also excluded. The data that were missing were: snoring in 36 participants, gender in 5, SBP in 36, DBP in 47, BMI in 27, ESS in 42, sleep data in 18, neck circumference in 23, hip circumference in 50 and waist circumference in 32. The characteristics of the subjects involved in the study are presented in Table 1 .
Using one way ANOVA (for normally distributed) or Kruskal Wallis (for non normally distributed) or x 2 test (for categorical variables) there were signifi cant differences between OSAHS severity and sex, age, BMI, neck and waist circumference, systolic and diastolic BP, snoring, ODI, ESS and 4-V. When post hoc analysis was performed for normally distributed variables (age: F=11.74, p<0,001, ESS: F=31.043, p<0.001) and Kruskal-Wallis for non normally distributed variables, in different OSAHS severity groups, the statistically signifi cant differences were more limited as shown in Figures 1 and 2.
There were signifi cant differences for BMI, waist and hip circumference between no and mild OSAHS in both men and women (p<0.005) and for all the former and additionally neck circumference between moderate and severe OSAHS for both men and women (p<0.001) ( Figure 1 ).In both genders, there were signifi cant differences between OSAHS severity groups for AHI and ODI (p<0.001) (Figure 2 ). The 4-V differed signifi cantly between no and mild (p=0.006 for men and p=0.015 for women) and between moderate and severe OSAHS (p<0.001 for men and p=0.003 for women), but did not differ between mild and moderate OSAHS in both genders ( Figure 2 ). For BP (that is not included in the former fi gures) the only statistically signifi cant difference was for Diastolic BP between mild and moderate OSAHS for both men and women (p<0.05).
In our population, 746 men reported snoring (no OSAHS =122, mild OSAHS = 94, moderate OSAHS=145, severe OSAHS =385) with significant The predictive values of the ESS were for mild OSAHS: sensitivity 32%, specifi city 51%, PPV 9%, NPV 85%, for moderate: sensitivity 44%, specifi city 52%, PPV 17%, NPV 81% and for severe: sensitivity 56%, specifi city 63%, PPV 60%, NPV 60%.
A good positive and highly signifi cant correlation was found between the 4-V ≥14 and mild (x Tables 2, 3 and 4. For a cut-off ≥11 the predictive values were better for AHI ≥5, apart from sensitivity and NPV that improved for AHI ≥30 (Table 2) . For a cut-off ≥14, the sensitivity was worse than that of a cut-off ≥11, but specifi city, PPV, AUC and OR were better (Table 3) . Differences in the predicting values of the two 4-V cut-off values for different severity groups and between genders are presented in Table 4 . For 4-V ≥11, sensitivity was high for all severity groups, but specifi city was very low in men, but the opposite was found for women with high specifi city and low sensitivity (Table 4 ). For 4-V ≥14 the predictive values improved with the severity of the syndrome for men, but for this cut-off, all women had scores less than 14 (all low probability for OSAHS). Sensitivity was worse but specifi city was better (Table 4) .
When we calculated the predictive values of 4-V of the patients with positive ESS (>10) for a cut off ≥11 they were: sensitivity 80.1%, specifi city 34.7%, PPV 71.4%, NPV 46.2%, LR(+)/LR(-) 1.22/0.6, OR:2.14 (CI 95% 1.6-2.9), AUC 0.57 (CI 95% 0.54-0.61) and for a cut off ≥14: sensitivity 55%, specifi city 74.5%, PPV 81.5%, NPV 50%, LR(+)/LR(-): 2.16/0.6, OR 3.6 (CI 95%, 2.7-4.8), AUC 0.65 (CI 95% 0.62-0.68) (for AHI ≥15). The above values did not differ with the predictive values presented in Tables 2 and 3 for AHI≥15.
DISCUSSION
The aim of our study was to validate the 4 Variable Screening Tool in order to evaluate whether it could be used for the identifi cation of patients at risk of OSAHS in a sleep clinic in Caucasian population. As the incidence of OSAHS is increasing and the financial support is decreasing, it is crucial to assess the patients with the higher risk for OSAHS with an effective screening tool in order to prioritize them for a sleep study.
The 4-V was designed and validated in Asian population 5 and for a cut-off ≥11, sensitivities 74% and 95.2% for respiratory disturbance index (RDI) ≥15 and RDI≥30 respectively and specifi cities of 66.1% and 61% for RDI≥15 and RDI≥30 respectively were found. 5 When a cutoff ≥14 was used, sensitivity was worse (33.3% and 57.1% for RDI≥15 and RDI≥30 respectively), but specifi city improved (94.1% and 91.3% for RDI≥15 and RDI≥30 respectively). 5 In our study, both cut-offs ≥11 and ≥14 were validated. For a cut-off ≥11, our sensitivities were similar with those of Takegami et al for AHI≥15 but lower for AHI≥30 and specifi cities were lower in both groups. For the cut-off ≥14, our sensitivities were slightly better but specifi cities were lower than those of Takegami 5 but higher than those of cut-off ≥11. In the study of Silva et al 8 that analyzed community population from the Sleep Heart Health Study (SHHS) only the cutoff ≥14 was evaluated. In that study, sensitivities were found to be lower (24.7% for moderate and 41.5% for severe OSAHS) than in our study (38.5% and 61% respectively) and specifi cities (93.2% for both moderate and severe OSAHS) were higher from those of our study (53% and 69% respectively), but similar with the specifi cities of Takegami et al 5 for a cut-off≥14. In our study, 4-V did not differ signifi cantly between mild and moderate OSAHS. However, mild OSAHS was not assessed in the studies of Takegami and Silva et al. 5, 8 When the 4-V was applied to different severity groups of OSAHS (Table 4) sensitivity, specifi city, PPV, LR+, AUC raised, but NPV, LR-decreased as the AHI increased. Additionally, for both cut-offs the 4-V had rather low NPV (46.5% and 45% respectively) in patients with AHI≥15 implying that about half of patients with OSAHS may not be diagnosed.The LR is a parameter used to assess how good a diagnostic test is and has the advantage over sensitivity and specifi city because it is less likely to change with the prevalence of the disorder. The LR+ increased and LR-decreased with the severity of OSAHS. In Table 4 for cut-off ≥11, the ORs were not statistically signifi cant (95% CIs included 1) in mild and moderate OSAHS, but they were signifi cant in severe. For cut-off ≥14, all the ORs were statistically signifi cant. So, as based on our fi ndings, the predictive values of 4-V improved with the severity of OSAHS. Additionally there were signifi cant differences in the predictive values of 4-V between genders, with very high specifi city for both cut-offs in women (100% for 4-V≥14) but very low sensitivity. For men, sensitivity reached 96% for cut-off ≥11, but specifi city was very low for all severity groups and for cut-off ≥14 the predictive values improved with the severity of the disease with the best predictive values in severe OSAHS group.
Key anatomical risk factors for the development of OSAHS include both obesity and craniofacial morphology, with more severe craniofacial skeletal abnormalities in the non-obese patients. However, obesity and craniofacial skeletal abnormalities may overlap. 12 It has been found that compared with Caucasians, Asians have greater restriction in skeletal measurements as a smaller maxilla, a shorter anterior cranial base, smaller and retropositioned mandible. 13, 14 Caucasians are more obese, whereas the cranial base dimensions of Asians are signifi cantly decreased.
14 In the study of Takegami et al   5 neck circumference was not found to be an important predictive variable for OSAHS identifi cation. However in Caucasians neck circumference is an important indicator of OSAHS. 15, 16 In our population neck circumference differed signifi cantly as OSAHS severity worsened (Figure 1 ). This could be a reason of the differences between our fi ndings and those of Takegami et al.
Daytime sleepiness is a common symptom of OSAHS and the ESS is a questionnaire assessing subjective daytime sleepiness. In our population the predictive variables of the ESS for OSAHS diagnosis were similar with those of 4-V≥14 (Table 4 ). However ESS is subjective and may underestimate sleepiness, whereas 4-V is more objective. For a cut-off≥11, the 4-V had better sensitivity, but worse specifi city than the ESS. When the 4-V was applied in patients with ESS>10 (sleepy patients) the predictive values did not change signifi cantly. So when 4-V and ESS were combined the predictive values did not improve.
For the calculation of 4-V we used the BMI categories as indicated in the study of Takegami that differ from those of the World Health Organization (WHO) BMI classification. 17 WHO definition for overweight and obesity differ among Asians with BMI cut-offs (23 and 25 kg/m 2 , respectively), i.e. lower than the cut-offs used for Caucasians (25 and 30 kg/m 2 , respectively). For a similar BMI, Asians have proportionally more fat compared with Caucasians and the BMI level is probably not a good marker of obesity for the comparison between them. 18 We used the same cut-offs with Takegami et al and this could be referred as a limitation of our study but our objective was to evaluate the utility of the 4-V as it was developed from Takegami when applied on Caucasian population. When we applied the WHO BMI classifi cation (BMI<18.5, 18.5-24.9, 25-29.9, 30-34.9,35-39.9,>40) the 4V differed signifi cantly from the one calculated with Takegami's BMI cut-offs (12±2.4 vs. 13.3±2.5, p<0.001). Using WHO BMI classifi cation for cut-off ≥11, 623 patients were diagnosed with AHI>5 whereas using Takegami's BMI cut-offs 661. For cut-off ≥14 only 282 patients were diagnosed with AHI >5, whereas using Takegami's BMI cut-offs 477. However, our scope was to evaluate the existing equation from Takegami and not to create a new predictive equation for our population. There are studies for the Greek population with such equations 19 that involve gender, BMI, neck circumference and excessive daytime sleepiness.
In a meta-analysis, 2 the STOP and STOP-Bang (S-B), the Berlin questionnaire (BQ), the American Society of Anesthesiologists (ASA) checklist, the Sleep Questionnaire and the sleep disorders questionnaire (SDQ) were evaluated. The ESS was found to be the least accurate and BQ and SDQ the most accurate to screen OSAHS. The S-B was an excellent method for severe OSAHS prediction due to its simplicity. In a systematic review, the Wisconsin and BQ were found to have the highest sensitivity and specifi city, 4 but no defi nite conclusion was made regarding the most accurate questionnaire for the prediction of OSAHS. Silva et al 8 evaluated apart from 4-V, the ESS, Stop and S-B in the general population. They found that the S-B had the highest sensitivity and the 4-V had the highest specifi city. The ESS was not as effective to predict OSAHS as Stop, S-B and 4-V.
An important limitation of our study was the fact that it was retrospective and included subjects not from the general population, but from a 'preselected group' of patients visiting a Sleep Clinic. This could be a reason for the difference in the predictive values of 4-V in our population. Additionally there was a signifi cant male predominance in our population as our study was retrospective and the scope was to evaluate 4-V in the unselected population visiting a sleep clinic. It is known that there is a predominance of males in OSAHS in community-based studies (2-3:1) due to the androgenic patterns of body fat distribution with deposition of fat in the trunk and the neck area and possibly due to the effect of sex hormones in the neurologic control of upper airway dilating muscles and ventilation. 20, 21 Also in sleep center-based studies male-to-female ratio of may reach up to 8:1 (in our study 2.8:1) as women often underreport the cardinal symptoms suggestive of of sleep apnea (loud snoring, witnessed apneas, sleepiness) leading to underreferral to sleep centers. This could also explain the marked male predominance. 22 Another limitation of our study was that the majority of our population reported snoring. Snoring, usually loud, habitual, and bothersome to others, is one of the most common nocturnal symptoms of OSAHS and probably the most common symptom of patients visiting a sleep clinic. In our population most men reported snoring with signifi cant correlation between OSAHS severity and snoring, but women underreported snoring with no signifi cant correlation between OSAHS severity and snoring. However, the scope of our study was to evaluate the 4-V in a sleep clinic setting with no selection of the population but in a real life setting.
As a conclusion, in Caucasian general population 8 and Caucasian population visiting a sleep clinic the sensitivity of the 4-V was low to predict OSAHS. We found that in a Caucasian population visiting a sleep clinic 4-V may miss cases suffering from OSAHS (relatively low sensitivity and NPV) but it has rather good specifi city i.e classifying fewer normal persons as high-risk for OSAHS especially for a cutoff ≥14. However the predictive values differed between genders with higher sensitivity for men, but high specifi city in women. In sleep centers (high risk for OSAHS) screening tools with high sensitivities should be used in order to avoid missing cases but also suffi cient specifi city is essential in order to eliminate unnecessary testing. However further studies are needed to determine the most appropriate cut-off point for Caucasian population and to establish a screening strategy including questionnaires with portable devices for sleep apnea detection in the general population.
